Recent progress in health effects and biosynthesis of lacto-N-tetraose, the most dominant core structure of human milk oligosaccharide
暂无分享,去创建一个
[1] W. Mu,et al. Biosynthesis of human milk oligosaccharides via metabolic engineering approaches: current advances and challenges. , 2022, Current opinion in biotechnology.
[2] W. Mu,et al. Recent progress on health effects and biosynthesis of two key sialylated human milk oligosaccharides, 3'-sialyllactose and 6'-sialyllactose. , 2022, Biotechnology advances.
[3] J. Gaddy,et al. Recent advances on human milk oligosaccharide antimicrobial activity. , 2022, Current opinion in chemical biology.
[4] Xing Zhang,et al. Enzymatic and chemoenzymatic synthesis of human milk oligosaccharides and derivatives. , 2022, Carbohydrate polymers.
[5] N. Ab Mutalib,et al. Exploring the Potential of Human Milk and Formula Milk on Infants’ Gut and Health , 2022, Nutrients.
[6] W. Mu,et al. Designing a Highly Efficient Biosynthetic Route for Lacto-N-Neotetraose Production in Escherichia coli. , 2022, Journal of agricultural and food chemistry.
[7] D. Casero,et al. Human Milk Oligosaccharides Impact Cellular and Inflammatory Gene Expression and Immune Response , 2022, Frontiers in Immunology.
[8] Tao Zhang,et al. Engineering Escherichia coli for the High-Titer Biosynthesis of Lacto-N-tetraose. , 2022, Journal of agricultural and food chemistry.
[9] W. Mu,et al. Pathway Optimization and Uridine 5'-Triphosphate Regeneration for Enhancing Lacto-N-Tetraose Biosynthesis in Engineered Escherichia coli. , 2022, Journal of agricultural and food chemistry.
[10] M. Marzorati,et al. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro , 2022, Nutrients.
[11] Kento Koketsu,et al. Transporter Engineering Enables the Efficient Production of Lacto-N-triose II and Lacto-N-tetraose in Escherichia coli. , 2022, Journal of agricultural and food chemistry.
[12] X. Biarnés,et al. Enzymatic Hydrolysis of Human Milk Oligosaccharides. The Molecular Mechanism of Bifidobacterium Bifidum Lacto-N-biosidase , 2022, ACS catalysis.
[13] C. Lebrilla,et al. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites , 2022, Frontiers in Molecular Biosciences.
[14] W. Mu,et al. Human Milk Oligosaccharides: The New Gold Standard for Premium Infant Formula. , 2022, Journal of agricultural and food chemistry.
[15] F. Lisacek,et al. In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis , 2022, Scientific Reports.
[16] P. de Vos,et al. Human milk oligosaccharides and non-digestible carbohydrates reduce pathogen adhesion to intestinal epithelial cells by decoy effects or by attenuating bacterial virulence. , 2021, Food research international.
[17] Feitong Liu,et al. Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function. , 2021, Carbohydrate polymers.
[18] A. Meyer,et al. Improvement of the Transglycosylation Efficiency of a Lacto-N-Biosidase from Bifidobacterium bifidum by Protein Engineering , 2021, Applied Sciences.
[19] M. J. Yebra,et al. Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose , 2021, Scientific Reports.
[20] W. Mu,et al. Metabolic Engineering of Escherichia coli for Efficient Biosynthesis of Lacto-N-tetraose Using a Novel β-1,3-Galactosyltransferase from Pseudogulbenkiania ferrooxidans. , 2021, Journal of agricultural and food chemistry.
[21] S. Jennewein,et al. Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth , 2021, Nutrients.
[22] W. Mu,et al. Metabolic Engineering of Escherichia coli for Lacto-N-triose II Production with High Productivity. , 2021, Journal of agricultural and food chemistry.
[23] A. Planas,et al. Transglycosylation Activity of Engineered Bifidobacterium Lacto-N-Biosidase Mutants at Donor Subsites for Lacto-N-Tetraose Synthesis , 2021, International journal of molecular sciences.
[24] Lianyan L Xu,et al. Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections. , 2021, ACS infectious diseases.
[25] Xiaoying Zhou,et al. Sialylated human milk oligosaccharides prevent intestinal inflammation by inhibiting toll like receptor 4/NLRP3 inflammasome pathway in necrotizing enterocolitis rats , 2021, Nutrition & Metabolism.
[26] Daniel Patrick Smith,et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis , 2020, Gut.
[27] W. Mu,et al. Recent advances on 2′-fucosyllactose: physiological properties, applications, and production approaches , 2020, Critical reviews in food science and nutrition.
[28] Aina Gotoh,et al. Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation , 2019, Nutrients.
[29] Hai Yu,et al. A Bacterial β1-3-Galactosyltransferase Enables Multigram-Scale Synthesis of Human Milk Lacto-N-tetraose (LNT) and Its Fucosides. , 2019, ACS catalysis.
[30] F. Ren,et al. Human Milk Oligosaccharides Protect against Necrotizing Enterocolitis by Inhibiting Intestinal Damage via Increasing the Proliferation of Crypt Cells. , 2019, Molecular nutrition & food research.
[31] B. Nidetzky,et al. Lacto-N-tetraose synthesis by wild-type and glycosynthase variants of the β-N-hexosaminidase from Bifidobacterium bifidum. , 2019, Organic & biomolecular chemistry.
[32] P. de Vos,et al. Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non‐Digestible Carbohydrates , 2019, Molecular nutrition & food research.
[33] Steven D. Townsend,et al. Sialylated variants of lacto-N-tetraose exhibit antimicrobial activity against Group B Streptococcus. , 2019, Organic & biomolecular chemistry.
[34] G. Kang,et al. Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection , 2018, Nature Communications.
[35] M. Mikš,et al. Preclinical safety evaluation of the human‐identical milk oligosaccharide lacto‐N‐tetraose , 2018, Regulatory toxicology and pharmacology : RTP.
[36] D. Sela,et al. Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infantis Physiology , 2018, Front. Nutr..
[37] P. Thomson,et al. Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization. , 2017, Food microbiology.
[38] R. Dilger,et al. Dietary Sialyllactose Influences Sialic Acid Concentrations in the Prefrontal Cortex and Magnetic Resonance Imaging Measures in Corpus Callosum of Young Pigs , 2017, Nutrients.
[39] S. Thurl,et al. Systematic review of the concentrations of oligosaccharides in human milk , 2017, Nutrition reviews.
[40] M. Estes,et al. Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells. , 2017, The Journal of nutrition.
[41] D. Aronoff,et al. Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus. , 2017, ACS infectious diseases.
[42] Shujiro Okuda,et al. Molecular Insight into Evolution of Symbiosis between Breast-Fed Infants and a Member of the Human Gut Microbiome Bifidobacterium longum. , 2017, Cell chemical biology.
[43] Steven D. Townsend,et al. Synthesis of lacto-N-tetraose. , 2017, Carbohydrate research.
[44] D. van Sinderen,et al. Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways , 2016, Scientific Reports.
[45] Takuji Yamada,et al. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development , 2016, Nature Communications.
[46] Tanya Yatsunenko,et al. Dietary Isomers of Sialyllactose Increase Ganglioside Sialic Acid Concentrations in the Corpus Callosum and Cerebellum and Modulate the Colonic Microbiota of Formula-Fed Piglets. , 2016, The Journal of nutrition.
[47] David F. Smith,et al. Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus , 2015, Nature Communications.
[48] Brian F. Pfleger,et al. Efflux systems in bacteria and their metabolic engineering applications , 2015, Applied Microbiology and Biotechnology.
[49] P. Forsythe,et al. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model , 2015, Allergy.
[50] J. Klassen,et al. Recognition of human milk oligosaccharides by bacterial exotoxins. , 2015, Glycobiology.
[51] G. Sprenger,et al. Galactose-limited fed-batch cultivation of Escherichia coli for the production of lacto-N-tetraose. , 2015, Enzyme and microbial technology.
[52] J. Delgado-García,et al. Effects of a human milk oligosaccharide, 2'-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. , 2015, The Journal of nutritional biochemistry.
[53] G. Sprenger,et al. Synthesis of the Human Milk Oligosaccharide Lacto‐N‐Tetraose in Metabolically Engineered, Plasmid‐Free E. coli , 2014, Chembiochem : a European journal of chemical biology.
[54] Hannah D. Holscher,et al. Human milk oligosaccharides influence maturation of human intestinal Caco-2Bbe and HT-29 cell lines. , 2014, The Journal of nutrition.
[55] K. Bum-Erdene,et al. Galectin-3 interactions with glycosphingolipids. , 2014, Journal of molecular biology.
[56] K. Fukuda,et al. Recent Advances in Studies on Milk Oligosaccharides of Cows and Other Domestic Farm Animals , 2013, Bioscience, biotechnology, and biochemistry.
[57] Lars Bode,et al. Human milk oligosaccharides: every baby needs a sugar mama. , 2012, Glycobiology.
[58] D. Mills,et al. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. , 2012, Anaerobe.
[59] M. Kitaoka,et al. Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. , 2012, Glycobiology.
[60] Lars Bode,et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats , 2011, Gut.
[61] G. Armstrong,et al. Binding of Clostridium difficile toxins to human milk oligosaccharides. , 2011, Glycobiology.
[62] J. German,et al. Oligosaccharide Binding Proteins from Bifidobacterium longum subsp. infantis Reveal a Preference for Host Glycans , 2011, PloS one.
[63] Peng George Wang,et al. Characterization and synthetic application of a novel beta1,3-galactosyltransferase from Escherichia coli O55:H7. , 2009, Bioorganic & medicinal chemistry.
[64] K. Fukuda,et al. Chemical characterization of oligosaccharides in chimpanzee, bonobo, gorilla, orangutan, and siamang milk or colostrum. , 2009, Glycobiology.
[65] B. Priem,et al. A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. , 2002, Glycobiology.
[66] G. Sawatzki,et al. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. , 2000, The American journal of clinical nutrition.
[67] T. Lagergård,et al. Inhibition of Attachment of Streptococcus pneumoniae and Haemophilus influenzae by Human Milk and Receptor Oligosaccharides , 1986 .
[68] G. Magnusson,et al. Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells , 1983, The Journal of experimental medicine.